EC Number | Application | Comment | Organism |
---|---|---|---|
1.3.1.14 | medicine | enzyme is a part of the pyrimidine biosynthesis pathway and plays a role as target for the chemotherapy of parasitic and neoplastic diseases | Faecalicatena orotica |
1.3.1.14 | pharmacology | drug design based upon selective enzyme inhibition | Faecalicatena orotica |
EC Number | General Stability | Organism |
---|---|---|
1.3.1.14 | dithiothreitol stabilizes | Faecalicatena orotica |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.3.1.14 | (R,R)-5-benzyl-3-(1-carboxy-2-phenylethyl)hydantoin | - |
Faecalicatena orotica | |
1.3.1.14 | (S)-5-benzyl-3-carboxymethylhydantoin | - |
Faecalicatena orotica | |
1.3.1.14 | (S)-N-carboxymethyl-N'-(1-carboxy-2-phenylethyl)urea | - |
Faecalicatena orotica | |
1.3.1.14 | (S,S)-5-benzyl-3-(1-carboxy-2-phenylethyl)hydantoin | - |
Faecalicatena orotica | |
1.3.1.14 | (S,S)-N,N'-bis(1-carboxy-2-phenylethyl)urea | - |
Faecalicatena orotica | |
1.3.1.14 | (S,S)-N-(1-carboxyethyl)-N'-(1-carboxy-2-phenylethyl)urea | 4 mM, 20% inhibition | Faecalicatena orotica | |
1.3.1.14 | 3-carboxymethylhydantoin | - |
Faecalicatena orotica | |
1.3.1.14 | 5-benzyl-3-(1-carboxy-2-phenylethyl)-1-methylhydantoin | - |
Faecalicatena orotica | |
1.3.1.14 | 5-Benzyl-3-(1-carboxy-2-phenylethyl)hydantoin | time-dependent irreversible inhibition at the active site, mechanism | Faecalicatena orotica | |
1.3.1.14 | hydantoin | derived from alpha-amino acids, weak competitive inhibitors, compounds with a benzyl goup are better inhibitors | Faecalicatena orotica | |
1.3.1.14 | isopropyl hydantoin | - |
Faecalicatena orotica | |
1.3.1.14 | N,N'-bis(carboxymethyl)urea | - |
Faecalicatena orotica |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.3.1.14 | dihydroorotate + NAD+ | Faecalicatena orotica | biosynthesis of pyrimidines | orotate + NADH + H+ | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.3.1.14 | Faecalicatena orotica | - |
identical with Clostridium oroticum | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.3.1.14 | (S)-dihydroorotate + NAD+ | - |
Faecalicatena orotica | orotate + NADH + H+ | - |
? | |
1.3.1.14 | dihydroorotate + NAD+ | biosynthesis of pyrimidines | Faecalicatena orotica | orotate + NADH + H+ | - |
? |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
1.3.1.14 | 25 | - |
assay at | Faecalicatena orotica |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
1.3.1.14 | 6.5 | - |
pH of assay medium | Faecalicatena orotica |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.3.1.14 | flavin | flavoprotein with two different flavins, probably FAD and FMN | Faecalicatena orotica | |
1.3.1.14 | flavin | NAD+-linked flavoprotein | Faecalicatena orotica |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.3.1.14 | 0.4 | - |
(S,S)-N,N'-bis(1-carboxy-2-phenylethyl)urea | - |
Faecalicatena orotica | |
1.3.1.14 | 0.6 | - |
5-benzyl-3-(1-carboxy-2-phenylethyl)-1-methylhydantoin | - |
Faecalicatena orotica | |
1.3.1.14 | 0.7 | - |
(S)-N-carboxymethyl-N'-(1-carboxy-2-phenylethyl)urea | - |
Faecalicatena orotica | |
1.3.1.14 | 0.7 | - |
(S,S)-5-benzyl-3-(1-carboxy-2-phenylethyl)hydantoin | - |
Faecalicatena orotica | |
1.3.1.14 | 0.9 | - |
(R,R)-5-benzyl-3-(1-carboxy-2-phenylethyl)hydantoin | - |
Faecalicatena orotica | |
1.3.1.14 | 2.3 | - |
(S)-5-benzyl-3-carboxymethylhydantoin | - |
Faecalicatena orotica | |
1.3.1.14 | 2.6 | - |
N,N'-bis(carboxymethyl)urea | - |
Faecalicatena orotica | |
1.3.1.14 | 4.5 | - |
3-carboxymethylhydantoin | - |
Faecalicatena orotica |